Detalhe da pesquisa
1.
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.
Lancet Oncol
; 24(4): e161-e171, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990614
2.
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups.
Lancet Oncol
; 24(11): e438-e450, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922934
3.
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.
Lancet Oncol
; 24(8): e344-e354, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541280
4.
OptImal Gamma kNife lIghTnIng sOlutioN (IGNITION) score to characterize the solution space of the Gamma Knife FIP optimizer for stereotactic radiosurgery.
J Appl Clin Med Phys
; 24(6): e13936, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36855958
5.
A study on inter-planner plan quality variability using a manual planning- or Lightning dose optimizer-approach for single brain lesions treated with the Gamma Knife® Icon™.
J Appl Clin Med Phys
; 24(11): e14088, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37415385
6.
Relationship between insurance status and interhospital transfers among cancer patients in the United States.
BMC Cancer
; 22(1): 121, 2022 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35093015
7.
Flexible endoscopic incisional therapy for Zenker's diverticulum (FEIT-Z) is an effective treatment for surgical failures or non-operative patients.
Surg Endosc
; 36(12): 8863-8868, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35578048
8.
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
J Neurooncol
; 155(3): 297-306, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34689306
9.
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
J Neurooncol
; 155(3): 363-372, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761331
10.
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
Cancer
; 126(12): 2821-2828, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154928
11.
Adagrasib in Non-Small-Cell Lung Cancer.
N Engl J Med
; 387(13): 1238-1239, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170508
12.
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition.
Acta Neuropathol
; 139(6): 1071-1088, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303840
13.
Early imaging marker of progressing glioblastoma: a window of opportunity.
J Neurooncol
; 148(3): 629-640, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32602020
14.
Effectiveness of Radiofrequency Ablation in the Treatment of Painful Osseous Metastases: A Correlation Meta-Analysis with Machine Learning Cluster Identification.
J Vasc Interv Radiol
; 31(11): 1753-1762, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33012648
15.
A risk model for prediction of 30-day readmission rates after surgical treatment for colon cancer.
Int J Colorectal Dis
; 35(8): 1529-1535, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32377912
16.
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
N Engl J Med
; 374(14): 1344-55, 2016 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27050206
17.
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice.
J Neurooncol
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38743346
18.
NRG brain tumor specialists consensus guidelines for glioblastoma contouring.
J Neurooncol
; 143(1): 157-166, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30888558
19.
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.
J Neurooncol
; 144(1): 205-210, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31273577
20.
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
J Neurooncol
; 145(1): 97-105, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31456142